BCL6 and neoplasm: Significantly, iRGD-Exo electroporated with BCL6 siRNA inhibited tumor growth in vitro and in vivo; however, the equivalent dose of BCL6 siRNA delivery by blank-Exo had limited effect on inhibition of tumor growth.